CTRI/2014/06/004699
Recruiting
未知
eoadjuvant chemotherapy followed by radical concomitant radio-chemotherpy or radiotherapy in cervical cancer - A Retrospective Analysis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Cancer of Cervix
- Sponsor
- A
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Histologically confirmed FIGO stage Ib2\-IVa squamous, adeno or adenosquamous carcinoma of the cervix.
- •Received Neo\-adjuvant chemotherapy (NACT) followed by Chemo\-radiotherapy (CRT) or Radiotherapy (RT).
- •Minimum follow\-up of 2 years after completion of Chemo\-radiotherapy (CRT) / Radiotherapy (RT).
Exclusion Criteria
- •Incomplete definitive treatment.
- •Not received Chemo\-radiotherapy (CRT) / Radiotherapy (RT).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastasesThe CHARISMA randomized multicenter clinical trialEUCTR2013-004952-39-NLErasmus MC Cancer Institute224
Completed
Phase 3
eo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases ;The CHARISMA randomized multicenter clinical trialLiver metastases colorectal cancer1001981510017998NL-OMON44796Erasmus MC, Universitair Medisch Centrum Rotterdam224
Not yet recruiting
Not Applicable
Chemotherapy followed by versus surgery alone in high-risk patients with colorectal liver metastasesColorectal liver metastases, clinical risk score, high risk patients, colorectale levermetastasen, klinische risico score, hoog risico patientenNL-OMON27498Prof. Dr. C. VerhoefErasmus MC Cancer Institute224
Not yet recruiting
Phase 2
Neoadjuvant Chemotherapy followed by Pre-operative Chemoradiation and Consolidation Chemotherapy before Surgery in High Risk Rectal Cancer: Multicentric Phase II Study2024-517183-31-00Centro Di Riferimento Oncologico Di Aviano93
Completed
Not Applicable
To adjuvant chemotherapy after curative treatment of head and neck cancer A study of alternate-day administration definitive TS-1Head and neck cancerJPRN-UMIN000009856ational Center for Global health and Medicine Otolarygology55